These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 47700)

  • 1. The thyroid in ulcreative colitis and Crohn's disease. III. The daily fractional turnover of thyroxine.
    Järnerot G; Truelove SC; Warner GT
    Acta Med Scand; 1975; 197(1-2):89-94. PubMed ID: 47700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in thyroxine metabolism in Crohn's disease.
    Vierhapper H; Grubeck-Loebenstein B; Ferenci P; Lochs H; Bratusch-Marrain P; Waldhäusl W
    Hepatogastroenterology; 1981 Feb; 28(1):31-3. PubMed ID: 6783498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion.
    Järnerot G
    Acta Med Scand; 1975; 197(1-2):77-81. PubMed ID: 235826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
    Jarnum S; Jensen KB
    Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 metabolism in ulcerative colitis and Crohn's disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Clin Exp Immunol; 1977 Jun; 28(3):490-5. PubMed ID: 891024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis.
    Järnerot G; Azad Khan AK; Truelove SC
    Acta Med Scand; 1975; 197(1-2):83-7. PubMed ID: 1124663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy histamine in ulcerative colitis and Crohn's disease.
    Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
    Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition in patients with inflammatory bowel disease: a population-based study.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral conversion of T4 and T3 in man].
    Glöbel B; Berberich R; Oberhausen E
    Nucl Med (Stuttg); 1975 Jun; 14(2):106-18. PubMed ID: 809755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid metabolism and plasma protein turnover in Crohn's disease.
    Lenz K; Jensen KB; Jarnum S
    Scand J Gastroenterol; 1976; 11(7):721-7. PubMed ID: 996438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage turnover in Crohn's disease and ulcerative colitis.
    Meuret G; Bitzi A; Hammer B
    Gastroenterology; 1978 Mar; 74(3):501-3. PubMed ID: 631480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.